Gene profiling in active dermatitis lesions strengthens the diagnosis of allergic contact dermatitis - Supplemental Material

Published: 4 December 2023| Version 1 | DOI: 10.17632/kwzssbf9rb.1
Contributor:
marine lefevre

Description

Supplemental Material: Gene profiling in active dermatitis lesions strengthens the diagnosis of allergic contact dermatitis Marine-Alexia LEFEVRE MD/PhD1-2, Audrey NOSBAUM MD/PhD1-3, Amandine MOSNIER MSc1, Vanina LENIEF MSc1, Samuel SALQUE MSc1, Marie PICHOT MSc1, Lea MAHEUX MSc1, Lea BERTOLOTTI MD3, Florence HACARD MD3, Celine GRAVERIAU MD4, Pascale ZUKERVAR MD4, Anne-Laure BRETON GUITARIAN MD4, Fanny BOISLEVE PharmD/PhD5, Michelle ELBAZ PharmD5, Jean-François NICOLAS MD/PhD1-3, Marc VOCANSON PhD1 Affiliations: 1 CIRI, Centre International de Recherche en Infectiologie, (Team Epidermal Immunity and Allergy); INSERM, U1111; Univ Lyon; Université de Lyon 1; Ecole Normale Supérieure de Lyon; CNRS, UMR 5308, Lyon, France. 2 Department of Dermatology and Allergy, Centre Hospitalier Universitaire de St Etienne, Saint-Priest-en-Jarez, France. 3 Department of Allergy and Clinical Immunology, Centre Hospitalier Lyon-Sud, Pierre-Benite, France. 4 Private Dermatology Practice, Lyon, France 5 Chanel, Neuilly-sur-Seine, France. Background: Distinguishing between allergic and non-allergic forms of Contact Dermatitis (CD) is challenging and requires investigations based on patch-testing. Early detection of allergy biomarkers in active CD lesions could refine and simplify the management of CD patients. Objective: To characterize the molecular signatures of active CD lesions. Methods: We studied the expression of 12 allergy biomarkers by qRT-PCR in active lesions of 38 CD patients. Allergic CD (ACD) was diagnosed based on patch-test (PT) results and exposure assessment. Molecular signatures of active lesions, as well as positive PT reactions, were compared with those of reference chemical allergens and irritants. Results: 19 of the 38 CD patients reacted positively upon patch-testing and exposure assessment confirmed ACD diagnosis for 17 of them. Gene profiling of active CD lesions revealed two distinct molecular patterns: patients harboring signatures similar to reference allergens (n=23) or irritants (n=15). Among the 23 patients with an “allergy signature”, we found the 17 patients with confirmed ACD, while no culprit allergen was identified for the 6 other patients. Interestingly, the 15 patients without biomarker induction had negative PT, suggesting that they developed non-allergic CD reactions. Conclusion: Molecular signatures from active skin lesions may help to stratify CD patients and predict those suffering from allergic contact dermatitis.

Files

Categories

Dermatology, Biomarker, Allergy, Diagnosis, Contact Dermatitis, Research Article

Licence